AsEMV reported in April that
"EMVision is in the late stages of integration, testing and documentation to release its upgraded Gen 1
devices in May for activation and enrolment commencement of Stage 2 (pre-validation phase) of the
Company’s multi-site clinical trial."
I had assumed it would be a bit more advanced by 29th of the month.
This report says "activated". What does that mean, other than no scans have been performed.
Also, I was hoping for a bit of information about the algorithm. Last month we were told Hardware was performing as designed and that it was advancing AI algorithms and other imaging techniques. I anticipate information on this can only come after real cases are scanned and compared to MRI.
Ann: Stage 2 of Clinical Trial Activated, page-8
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
-0.060(2.91%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.13 | $1.99 | $251.9K | 123.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9762 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 2346 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |